Ying Wang

Director, Synthetic Vaccine R&D, Head of Flavivirus Programs at Codagenix

Dr. Ying Wang leads Codagenix’s vaccine development projects related to Flaviviruses such as Dengue and Zika. She was also the leading scientist in the recovery of COVI-VAC, Codagenix’s live attenuated vaccine against SARS-CoV-2. Prior to joining Codagenix, Dr. Wang was a postdoctoral fellow and then a Research Scientist at SUNY Stony Brook where she studied cellular signaling, developmental biology, neuronal and behavioral science. She holds a PhD in Biochemistry from the Chinese University of HK.

Location

Lake Grove, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Codagenix

Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development.


Industries

Employees

11-50

Links